Acrivon Therapeutics Inc.... (ACRV)
NASDAQ: ACRV
· Real-Time Price · USD
1.30
-0.04 (-2.99%)
At close: Sep 04, 2025, 3:59 PM
1.38
6.14%
Pre-market: Sep 05, 2025, 08:20 AM EDT
-2.99% (1D)
| Bid | 1.28 |
| Market Cap | 40.89M |
| Revenue (ttm) | 848K |
| Net Income (ttm) | -85.96M |
| EPS (ttm) | -2.24 |
| PE Ratio (ttm) | -0.58 |
| Forward PE | -0.62 |
| Analyst | Buy |
| Ask | 1.4 |
| Volume | 218,171 |
| Avg. Volume (20D) | 302,285 |
| Open | 1.36 |
| Previous Close | 1.34 |
| Day's Range | 1.30 - 1.36 |
| 52-Week Range | 1.05 - 10.00 |
| Beta | 1.67 |
About ACRV
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ACRV
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ACRV stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts4 months ago
-17.59%
ACRV stock has given up its prior gain. Acrivion T...
Unlock content with
Pro Subscription
4 months ago
-17.59%
Acrivion Therapeutics shares are trading higher after the company announced it will present data from its analysis of ACR-2316.
